The information previously contained on these webpages were authorized under the 2009 H1N1 Influenza Emergency Use Authorizations (EUAs). As of June 23, 2010, the EUAs have been terminated and this information is no longer current.
November 13, 2009
A public health emergency has been declared by the Secretary of Health and Human Services because of the outbreak of the 2009 H1N1 influenza virus. This fact sheet will refer to the virus as 2009 H1N1 influenza virus. The Food and Drug Administration (FDA) has authorized the emergency use of the Roche RealTime ready Influenza A/H1N1 Detection Set to test for the presence of the 2009 H1N1 influenza virus in clinical respiratory specimens. These specimens should be collected via nasopharyngeal swabs, nasal swabs, nasal washes or nasal aspirates from patients with signs and symptoms of respiratory infection. This authorization will terminate on April 26, 2010, when the emergency has ceased to exist, or when the authorization has been revoked, whichever is earlier. The information in this Fact Sheet is the minimum necessary to inform you of the significant known and potential risks and benefits of the emergency use of the Roche RealTime ready Influenza A/H1N1 Detection Set.
At this time, there are no FDA-approved/cleared tests that identify the existence of the 2009 H1N1 influenza virus in clinical specimens. Previously, the FDA granted Emergency Use Authorization for other tests intended to diagnose 2009 H1N1 influenza virus, see http://www.fda.gov/MedicalDevices/ Safety/EmergencySituations/ucm161496.htm for more information. To augment existing testing capacity, FDA has authorized the emergency use of the Roche RealTime ready Influenza A/H1N1 Detection Set on the LightCycler® 2.0 instrument to detect 2009 H1N1 influenza virus infections. Current information on 2009 H1N1 influenza virus, including case definitions and infection control guidelines, is available at http://www.cdc.gov/h1n1flu/. All information and guidelines, including those on testing for 2009 H1N1 influenza virus, may change as we continue to learn more about this disease. Please check CDC’s 2009 H1N1 influenza virus website regularly for the most current information.
The Roche RealTime ready Influenza A/H1N1 Detection Set test should be ordered only to diagnose 2009 H1N1 influenza virus infection. This test is authorized for use with nasopharyngeal swabs, nasal swabs, nasal washes or nasal aspirates. Specimen collection should be conducted according to the manufacturer’s instructions for the specimen collection device and sent to a qualified laboratory for analysis.
What does it mean if the specimen tests positive for the 2009 H1N1 influenza virus?
A positive test for 2009 H1N1 Influenza virus using the Roche RealTime ready Influenza A/H1N1 Detection Set indicates that the patient is infected with the 2009 H1N1 influenza virus. The test does not indicate the stage of infection. Laboratory test results should always be considered in the context of clinical observations and epidemiologic data in making a final diagnosis. For guidelines on managing patients please refer to “Interim Guidance for Infection Control for Care of Patients with Confirmed or Suspected Swine Influenza A (H1N1)Virus Infection in a Healthcare Setting” and “Interim Guidance on Antiviral Recommendations for Patients with Confirmed or Suspected Swine Influenza A (H1N1) Virus Infection and Close Contacts” at http://www.cdc.gov/h1n1flu/guidance/.
The Roche RealTime ready Influenza A/H1N1 Detection Set test has been designed to minimize the likelihood of false positive test results. However, in the event of a false positive result, the risks to patients could include any or all of the following: recommendations to limit contact with uninfected persons (including at home or at the workplace), a prescription of antiviral medication or other therapy, the impaired ability to detect and receive appropriate medical care for the true infection causing the flu like symptoms, or other unintended adverse effects.
What does it mean if the specimen tests negative for the 2009 H1N1 influenza virus?
Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other patient management decisions. The clinical features of the illness and the type and risk of exposure are the keys to making patient management and isolation decisions. A negative test result from the Roche RealTime ready Influenza A/H1N1 Detection Set test should not be interpreted as demonstrating that the patient does not have 2009 H1N1 influenza virus infection, if other aspects of the patient’s clinical presentation or recent epidemiologic exposures indicate 2009 H1N1 influenza virus infection is likely, and diagnostic tests for other causes of acute respiratory illness are negative.
US Customer Technical Support at 1-800-526-1247 or 1-800-428-5433
Healthcare providers will be contacted by Roche Diagnostics in the event of any significant new findings observed during the course of the emergency use of the Roche RealTime ready Influenza A/H1N1 Detection Set test.